Gemcitabine alone: Clinical Trials

6 trials of Gemcitabine alone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 not yet recruiting, 2 recruiting. 3 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Not yet recruiting 2, Completed 1
Phase 33Recruiting 2, Completed 1

Follow Gemcitabine alone: new trials by email Literature Review of Gemcitabine alone trials Research Report on Gemcitabine alone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
Tepotinib, Pemetrexed (Alimta), Vinorelbine - Advanced Non Small Cell Lung Cancer, MET Exon 14 Mutation
Phase 3RecruitingIntergroupe Francophone de Cancerologie Thoracique1332025-12-092025-12-17
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
6-Thio-2'-Deoxyguanosine, Cemiplimab, Docetaxel - Carcinoma, Non-Small -Cell Lung
Phase 3RecruitingMaia Biotechnology3002025-12-082026-01-12
Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer
Cyclophosphamide+Pemetrexed+5-Fluorouracil, Cyclophosphamide+Doxorubicin+5-Fluorouracil, Vindesine + Cisplatin - Locally Advanced Thyroid Gland Carcinoma, Thyroid Cancer
Phase 2Not yet recruitingWest China Hospital202024-12-012024-12-03
Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients
Astragalus + Gemcitabine, Gemcitabine alone - Pancreatic Cancer
Phase 2Not yet recruitingShenzhen University General Hospital1202024-02-012024-02-02
EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas
Gemcitabine alone, EndoTAG-1 and Gemcitabine - Adenocarcinoma, Metastasis
Phase 2CompletedMediGene2122005-09-012008-11-14
Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
Gemcitabine + Capecitabine, Gemcitabine alone - Pancreatic Cancer
Phase 3CompletedSwiss Cancer Institute3192001-06-012019-05-15

Conditions studied

Pancreatic Neoplasms (3)  ·  Adenocarcinoma (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Large Cell (1)  ·  Carcinoma, Squamous Cell (1)  ·  Neoplasm Metastasis (1)  ·  Thyroid Neoplasms (1)

Sponsors

Intergroupe Francophone de Cancerologie Thoracique (1)  ·  Maia Biotechnology (1)  ·  MediGene (1)  ·  Shenzhen University General Hospital (1)  ·  Swiss Cancer Institute (1)  ·  West China Hospital (1)

Countries

China (2)  ·  Austria (1)  ·  Czechia (1)  ·  France (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Romania (1)  ·  Switzerland (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  Ukraine (1)

Top investigators

Richard Herrmann, MD (1)  ·  Victor Zaporojan, Medical Doctor (1)  ·  Werner Scheithauer, MD (1)

Results publications

PMID 17538165, PMID 18249033, PMID 18669454, PMID 20877359, PMID 30636977